Beyond CAR-T:
Other Engineered Immune Cells

Inceptor Bio is excited to partner with Kineticos Life Sciences to bring you: Beyond CAR-T: Other Engineered Immune Cells. Mike Nicholson, CSO at Inceptor Bio, Chris Heery, CMO at Arcellx and SAB member at Inceptor Bio, and Mark Gilbert, Formerly of Juno Therapeutics and SAB member at Inceptor Bio discuss CAR-T for solid tumors, allogeneic CAR-T, CAR-NK and CAR-Macrophage, as well as manufacturing cell therapies.

Arrow

BACK TO INDEX